🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Drugs used in chemotherapy, such as gemcitabine, work in differe...
Status
Terminated
Location
Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School
Start Date
2006-04
Trial ID
NCT00323791
Mycobacterium avium complex (MAC) are ubiquitous organisms that cause isola...
Status
Completed
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2005-05-13
Trial ID
NCT00111397
Treatments Being Tested
RATIONALE: Studying the genes expressed in samples of tumor tissue from pat...
Status
Completed
Location
Multiple Locations
Start Date
2007-10-26
Trial ID
NCT00898261
Treatments Being Tested
We propose to develop novel diagnostic tests for severe sepsis and communit...
Status
Unknown
Location
Henry Ford Hospital
Start Date
2005-12
Trial ID
NCT00258869
RATIONALE: Drugs used in chemotherapy work in different ways to stop the gr...
Status
Completed
Location
Basingstoke and North Hampshire NHS Foundation Trust
Start Date
2006-08
Trial ID
NCT00454480
Treatments Being Tested
RATIONALE: Studying samples of blood and tissue from patients with cancer i...
Status
Completed
Location
Multiple Locations
Start Date
2010-04
Trial ID
NCT01139983
RATIONALE: Everolimus may stop the growth of cancer cells by blocking some ...
Status
Completed
Location
Mayo Clinic in Arizona
Start Date
2011-01-10
Trial ID
NCT01075321
This research trial studies biomarkers in predicting treatment response in ...
Status
Not Yet Recruiting
Location
National Cancer Institute of Canada Clinical Trials Group
Start Date
2012-05
Trial ID
NCT01595074
Treatments Being Tested
This study will assess the usefulness of a technique called complementary d...
Status
Completed
Location
National Naval Medical Center
Start Date
2000-06
Trial ID
NCT00005908
RATIONALE: Dasatinib may stop the growth of tumor cells by blocking some of...
Status
Terminated
Location
City of Hope Medical Center
Start Date
2008-09-03
Trial ID
NCT00788125